Focus on Adolescent Use of Club Drugs and "Other" Substances.
Janet F Williams, Leslie H. Lundahl
Pediatric clinics of North America December 1, 2019 DOI: 10.1016/j.pcl.2019.08.013 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Population | Adolescents |
| Keywords | Adolescents Club drugs Designer drugs Hallucinogens Inhalants Otc substances Adolescent substance use Drug experimentation Youth drug use Novel compounds Custom-designed drugs New psychoactive substances Sbirt intervention Proactive identification Vigilance Improved outcomes Substance use screening Adolescent intervention |
| Citations | 22 |
| Key findings | Clinicians must maintain vigilance to anticipate and recognize the new effects and drug-drug interactions arising from the wide variety of known and custom-designed substances used by adolescents. |
Abstract
Club drugs and "other" abusable substances are briefly overviewed as a reminder about the wide variety of known and unknown substances used by adolescents, the high potential for direct and interactive substance use effects to manifest acutely and chronically, and the vigilance needed to anticipate and recognize the new effects and drug-drug interactions arising as novel substances continue to be custom "designed," manufactured, and marketed to meet substance use trends. This article discusses dextromethorphan, flunitrazepam (Rohypnol), gamma-hydroxybutyrate, inhalants, ketamine, lysergic acid diethylamide, methylenedioxymethamphetamine, phencyclidine, Salvia divinorum (salvia), synthetic cannabinoids, and synthetic cathinones (bath salts).